NCT06553989

Brief Summary

One of the most common post-operative complications of gynaecological surgery, and in particular endometriosis surgery, is the formation of peritoneal adhesions. After laparotomy, it affects up to 90% of patients. Minimally invasive techniques (such as laparoscopy) reduce the risk of adhesion formation, but cannot totally prevent it. Adhesions can lead to chronic pelvic pain, dyspareunia, digestive disorders and infertility. Various strategies and devices have been developed to try and limit adhesion formation, but their effectiveness has not been fully proven in the literature. The only real treatment for adhesions is adhesiolysis, although adhesions often reform. The quality of surgery remains the best means of preventing adhesion formation. To reduce the morbidity associated with pelvic adhesions, it is essential to develop alternative, non-invasive, anti-adhesive methods such as manual osteopathic visceral mobilization.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
63

participants targeted

Target at P50-P75 for not_applicable

Timeline
28mo left

Started Jan 2025

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress36%
Jan 2025Sep 2028

First Submitted

Initial submission to the registry

August 8, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 14, 2024

Completed
6 months until next milestone

Study Start

First participant enrolled

January 27, 2025

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2027

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2028

Last Updated

February 4, 2025

Status Verified

January 1, 2025

Enrollment Period

2.6 years

First QC Date

August 8, 2024

Last Update Submit

January 31, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Quality of life with the EHP-30 questionnaire score

    Percentage change in baseline questionnaire score (EHP-30) between pre-operative visit and 1 year. The EHP-30 contains 30 items and ranges from 0 (best health) to 100 (worst health). The items in the baseline questionnaire are grouped into 5 main sub-domains: pain, control and powerlessness, emotional well-being, social support and self-image.

    1 year

Secondary Outcomes (15)

  • quality of life with score of the questionnaire EHP-30

    pre-operative, 6 months and 12 months

  • quality of life with score of the questionnaire GIQLI

    pre-operative, 6 months and 12 months

  • quality of life with score of the questionnaire FSFI

    pre-operative, 6 months and 12 months

  • quality of life with score of the questionnaire ICIQ-FLUTS

    pre-operative, 6 months and 12 months

  • quality of life with score of the questionnaire PCS

    pre-operative, 6 months and 12 months

  • +10 more secondary outcomes

Study Arms (2)

Control group

NO INTERVENTION

patients operated for endometriosis without osteopathic visceral mobilization

Experimental group

EXPERIMENTAL

patients operated for endometriosis with osteopathic visceral mobilization

Other: osteopatic visceral mobilization

Interventions

a combination of breathing and visceral mobilizations

Experimental group

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Woman of legal age
  • Indication for surgery for infiltrating endometriosis
  • Able to give informed consent to participate in research
  • Patient included in NO ENDO (national endometriosis observatory promoted by Clermont-Ferrand University Hospital)

You may not qualify if:

  • Indication for surgery for superficial endometriosis
  • Patient of legal age, under guardianship or trusteeship
  • Pregnant or breast-feeding patient
  • Patients not affiliated to the social security system
  • Patients who do not speak French
  • Patients under court protection
  • Simultaneous participation in another study
  • Refusal to participate.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU de Clermont-Ferrand

Clermont-Ferrand, France

RECRUITING

MeSH Terms

Conditions

Endometriosis

Condition Hierarchy (Ancestors)

Genital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Diseases

Study Officials

  • Nicolas Bourdel

    University Hospital, Clermont-Ferrand

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 8, 2024

First Posted

August 14, 2024

Study Start

January 27, 2025

Primary Completion (Estimated)

September 1, 2027

Study Completion (Estimated)

September 1, 2028

Last Updated

February 4, 2025

Record last verified: 2025-01

Locations